SEED Innovations Limited

SEED Innovations Limited is a UK-based investment company that offers shareholders exposure to early-stage health, wellness, and medical cannabis companies. The company focuses on investing in disruptive, high-growth life sciences and technology ventures, including sectors such as biotechnology, pharmaceuticals, artificial intelligence, and digital delivery. SEED Innovations Limited is quoted on the Alternative Investment Market (AIM) of the London Stock Exchange under the ticker symbol SEED.

The company's investment strategy involves identifying early-stage opportunities with upcoming investment catalysts, alongside more mature investments providing near-term liquidity. SEED Innovations Limited typically invests in companies with significant intellectual property rights and seeks to invest up to £100 million ($127.25 million) of enterprise value. The firm's geographical focus is primarily on North America and Europe, though investments may also be considered in other regions. The company is domiciled and incorporated as a limited liability company in Guernsey, with its registered office located at Suite 8, Upper House, 16-20 Smith Street, St. Peter Port, Guernsey.

As of March 2025, SEED Innovations Limited published its Annual Report and Audited Financial Statements for the year ended 31 March 2025. The company's portfolio includes investments in various sectors, with a particular emphasis on life sciences and technology ventures. The firm is committed to providing investors with access to opportunities typically reserved for venture capital firms, supporting the growth and success of each of its portfolio companies. For more information, visit the company's official website at https://seedinnovations.co/.